KR20200096567A - 크로몰린 조성물 및 그 방법 - Google Patents

크로몰린 조성물 및 그 방법 Download PDF

Info

Publication number
KR20200096567A
KR20200096567A KR1020207018938A KR20207018938A KR20200096567A KR 20200096567 A KR20200096567 A KR 20200096567A KR 1020207018938 A KR1020207018938 A KR 1020207018938A KR 20207018938 A KR20207018938 A KR 20207018938A KR 20200096567 A KR20200096567 A KR 20200096567A
Authority
KR
South Korea
Prior art keywords
cromoline
composition
microns
powder
pharmaceutically acceptable
Prior art date
Application number
KR1020207018938A
Other languages
English (en)
Korean (ko)
Inventor
데이비드 알. 엘마레
Original Assignee
더 제너럴 하스피탈 코포레이션
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US15/830,980 external-priority patent/US10525005B2/en
Application filed by 더 제너럴 하스피탈 코포레이션 filed Critical 더 제너럴 하스피탈 코포레이션
Publication of KR20200096567A publication Critical patent/KR20200096567A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
KR1020207018938A 2017-12-04 2017-12-28 크로몰린 조성물 및 그 방법 KR20200096567A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15/830,980 US10525005B2 (en) 2013-05-23 2017-12-04 Cromolyn compositions and methods thereof
US15/830,980 2017-12-04
PCT/US2017/064526 WO2019112552A1 (en) 2017-12-04 2017-12-28 Cromolyn compositions and methods thereof

Publications (1)

Publication Number Publication Date
KR20200096567A true KR20200096567A (ko) 2020-08-12

Family

ID=66751145

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020207018938A KR20200096567A (ko) 2017-12-04 2017-12-28 크로몰린 조성물 및 그 방법

Country Status (8)

Country Link
EP (1) EP3720429A4 (ja)
JP (1) JP2021505658A (ja)
KR (1) KR20200096567A (ja)
CN (1) CN111629719A (ja)
AU (1) AU2017442079A1 (ja)
CA (1) CA3084593A1 (ja)
MX (1) MX2020005615A (ja)
WO (1) WO2019112552A1 (ja)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2466863A1 (en) * 2001-11-29 2003-06-05 Emisphere Technologies, Inc. Oral pharmaceutical compositions comprising cromolyn sodium and an acylated amino acid
EP3563849A3 (en) * 2012-10-25 2020-02-12 The General Hospital Corporation Combination therapies for the treatment of alzheimer's disease and related disorders
EP2999337A4 (en) * 2013-05-23 2017-03-15 Aztherapies, Inc Methods for delivering cromolyn
EP3060205A4 (en) * 2013-10-22 2017-06-28 The General Hospital Corporation Cromolyn derivatives and related methods of imaging and treatment
US10265296B2 (en) * 2015-08-07 2019-04-23 Respivant Sciences Gmbh Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders
AU2016359674A1 (en) * 2015-11-23 2018-06-14 The General Hospital Corporation Compositions and methods for treating ischemic stroke

Also Published As

Publication number Publication date
AU2017442079A1 (en) 2020-06-25
MX2020005615A (es) 2020-11-25
JP2021505658A (ja) 2021-02-18
CA3084593A1 (en) 2019-06-13
EP3720429A1 (en) 2020-10-14
CN111629719A (zh) 2020-09-04
WO2019112552A1 (en) 2019-06-13
EP3720429A4 (en) 2021-09-15

Similar Documents

Publication Publication Date Title
AU2019271898B2 (en) Methods for delivering cromolyn
US11013686B2 (en) Cromolyn compositions and methods thereof
JP6758196B2 (ja) Ｃｏｐｄの治療におけるフルチカゾンフランカルボン酸エステル
US20190254967A1 (en) Method and system for the treatment of chroic copd with nebulized anticholinergic administrations
PT2398473E (pt) 5-(2-{[6-(2,2-difluoro-2-feniletoxi)hexil]amino}-1- hidroxietil)-8-hidroxiquinolin-2(1h)-ona para o tratamento da função pulmonar
KR20180119597A (ko) 염증 상태의 급성 악화의 치료를 위한 투약법
KR20200096567A (ko) 크로몰린 조성물 및 그 방법
JP2016027032A (ja) 慢性閉塞性肺疾患治療剤
WO2024062007A1 (en) Capsule inhaler for the administration of a phosphodiesterase-4 inhibitor

Legal Events

Date Code Title Description
E902 Notification of reason for refusal
E601 Decision to refuse application